Outlook Therapeutics director Faisal Ghiath Sukhtian acquires 95,398 common shares for $99,962.34

• Outlook Therapeutics director Sukhtian Faisal Ghiath bought 95,398 common shares at $1.05 per share.
• He reported direct ownership of 220,972 shares following the purchase.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Outlook Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001649989-26-000008), on July 29, 2026, and is solely responsible for the information contained therein.